Literature DB >> 2894074

Neurobiological studies of sensory gating in schizophrenia.

R Freedman1, L E Adler, G A Gerhardt, M Waldo, N Baker, G M Rose, C Drebing, H Nagamoto, P Bickford-Wimer, R Franks.   

Abstract

The sensory disturbance in schizophrenia is often described as an inability to filter out extraneous noise from meaningful sensory inputs. The neurobiological basis of this inability to filter has been examined using auditory evoked potentials, which are computerized averages of the brain's electrical response to sound. The sounds are presented in pairs to test the ability of the brain to inhibit, or gate, its response to a repeated stimulus. Schizophrenic patients lack the ability to gate the neuronal response shown by a particular wave, the P50 wave. The measurement of this deficit in human subjects and the exploration of its neurobiology in animals has produced evidence about several issues in the pathophysiology of schizophrenia: (1) the role of dopamine in improvement of sensory function in schizophrenic patients treated with neuroleptic drugs, (2) the interaction between familial or genetic deficits in sensory functioning in schizophrenic patients and possible abnormalities in dopamine metabolism, and (3) a mechanism by which noradrenergic hyperactivity in mania and other psychiatric illnesses might mimic some pathophysiological deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2894074     DOI: 10.1093/schbul/13.4.669

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  86 in total

1.  Relevance of attention in auditory sensory gating paradigms in schizophrenia A pilot study.

Authors:  Klevest Gjini; Scott Burroughs; Nash N Boutros
Journal:  J Psychophysiol       Date:  2011       Impact factor: 1.333

2.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

3.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

4.  Phenomenological dimensions of sensory gating.

Authors:  William P Hetrick; Molly A Erickson; David A Smith
Journal:  Schizophr Bull       Date:  2010-06-04       Impact factor: 9.306

5.  Nicotine suppresses the P13 auditory evoked potential by acting on the pedunculopontine nucleus in the rat.

Authors:  N Mamiya; R Buchanan; T Wallace; R D Skinner; E Garcia-Rill
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

Review 6.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

7.  Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.

Authors:  Merilyne C Waldo; Laurie Woodward; Lawrence E Adler
Journal:  Psychiatry Res       Date:  2009-12-02       Impact factor: 3.222

8.  Disruption of sensory gating by moderate alcohol doses.

Authors:  Alfredo L Sklar; Sara Jo Nixon
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

9.  P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory.

Authors:  Marijn Lijffijt; Scott D Lane; Stacey L Meier; Nash N Boutros; Scott Burroughs; Joel L Steinberg; F Gerard Moeller; Alan C Swann
Journal:  Psychophysiology       Date:  2009-06-08       Impact factor: 4.016

10.  Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.

Authors:  Victoria M Leavitt; Sophie Molholm; Walter Ritter; Marina Shpaner; John J Foxe
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.